Skip to main content
Daily market wrap · Wednesday, 15 July 2026
~2 min read

Nifty flat, internals firming — base, not breakdown

Fast breadth and net new highs held up after Tuesday's sell-off. The structural read is cautious but not deteriorating.
Stage2Stocks Market Desk
Nifty 50
24,079
+0.1% on the day
Regime
Weak but recovering
31th day · neutral-to-up
Breadth
44%
above 200-DMA · narrow
Adv / Dec
1,140 / 1,063
advancers ahead
52w highs / lows
175 / 82
net +93
Stage-2 share
35%
cohort widening

The tape is recovering, not rolling over. Tuesday's sharp sell-off — 334 advancers against 1,884 decliners — has been followed by two sessions of quietly firming internals, and today's flat Nifty close masks a market that is building a base rather than cracking one. Commit to this read: it is a dip inside a weak-but-recovering regime, not the start of a top, though the index sitting below its 200-day average and 8.5% off its 52-week high means the recovery has earned nothing yet.

Trajectory: the internals say base, not breakdown

The continuity series tells the story clearly. The fast short-term breadth gauge collapsed to 34.9 on the 8th, then climbed to 52.2 by the 13th — a five-session recovery — before Tuesday's -0.7% session pulled it back to 43.9. Today it nudged back to 45.6 with advancers leading decliners 1,140 to 1,063 and net new highs holding at 93, almost identical to Tuesday's 94 despite a weaker index. The slow structural breadth gauge, which tracks stocks above their 200-day average, has actually ticked up to 44.2 today after dipping to 43.3 on Tuesday — it has not broken down. The 5-day Stage-2 cohort is marginally softer at -0.7, but the 20-day figure is +5.9 and the 60-day is +25.2; the advancing cohort is widening on any meaningful timeframe, and the 5-day transition count of 39 stocks moving Stage 1 to 2 against 43 moving Stage 2 to 3 is a mild net negative worth watching but not a signal to panic on.

Leadership: Health Care and Real Estate doing the heavy lifting

On the day, Financials and Consumer Discretionary each added 0.7% and Health Care 0.5% — modest gains, but consistent with where the durable leadership sits. Health Care is up 20.5% over three months and 7.6% over one month; Real Estate is up 20.3% over three months and 11.6% over one month. Both sectors are also where the Stage-2 cohort is expanding fastest over the last 20 days, alongside Consumer Discretionary. Information Technology and Energy are the three-month laggards and are not where the screen is finding setups. Among names that cleared the screen, Knowledge Marine and Engineering Works — an Industrials name with a relative-strength rank of 98 — is the standout on that metric, while Spandana Sphoorty Financial is the only Financials name in the top setups, consistent with that sector's modest day-leadership rather than structural dominance.

Leading Stage-2 setups
StockSectorSetup% 1D
Bharat Seats LtdConsumer Discretionary9.4
Lokesh Machines LtdIndustrials9.4
Tirupati Forge LtdConsumer Discretionary9.4
Spandana Sphoorty Financial LtdFinancials9.2
Knowledge Marine & Engineering Works LtdIndustrials9.0
Macpower CNC Machines LtdIndustrials9.0
Fusion Finance LtdFinancials9.0
Euro India Fresh Foods LtdConsumer Staples9.0
Sector performance — cap-weighted, ranked by today’s move
Sector1D1M3MRSStage 2
Financials+0.7%+2.9%+2.3%6136%
Consumer Discretionary+0.7%+3.3%+6.9%6635%
Health Care+0.5%+7.6%+20.5%7451%
Industrials+0.5%+1.3%+16.8%6838%
Energy+0.5%+0.1%+0.6%5236%
Materials+0.4%-0.4%+6.0%6836%
Communication Services+0.1%+5.6%+13.5%6218%
Information Technology-0.3%+2.4%+0.1%3728%
Real Estate-0.5%+11.6%+20.3%5225%
Consumer Staples-0.5%-0.4%+4.9%5331%
Utilities-1.1%+0.7%+12.4%6223%
Breadth note
175 stocks are at or near new 52-week highs today — broad participation.
Work the same data live: open the full stock screener, watch the live market dashboard, or check the market-timing regime read. New to the method? Start with the four stages.

Stage2Stocks is an educational stage-analysis screener. These wraps describe what the screen shows across NSE cash equities — they are not investment advice, recommendations, or buy/sell calls. Always do your own research.

More market wraps